Privia Health Gr Q2 2024 Adj. EPS $0.19 Beats $0.05 Estimate, Sales $422.326M Miss $706.445M Estimate
Portfolio Pulse from Benzinga Newsdesk
Privia Health Group (NASDAQ: PRVA) reported Q2 2024 adjusted EPS of $0.19, significantly beating the estimate of $0.05. However, sales of $422.326 million missed the $706.445 million estimate by 40.22%. Sales increased by 2.17% year-over-year.
August 08, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Privia Health Group reported Q2 2024 adjusted EPS of $0.19, beating the estimate of $0.05 by 280%. However, sales of $422.326 million missed the $706.445 million estimate by 40.22%. Sales increased by 2.17% year-over-year.
The significant EPS beat is a positive indicator, but the large miss on sales estimates and only a slight year-over-year sales increase may neutralize the impact. Investors may have mixed reactions, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100